• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS INC ATELLICA IM ANTI-HEPATITIS B SURFACE ANTIGEN 2 (AHBS2); TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS INC ATELLICA IM ANTI-HEPATITIS B SURFACE ANTIGEN 2 (AHBS2); TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM) Back to Search Results
Model Number N/A
Medical Device Problem Code False Positive Result (1227)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/12/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Siemens investigated a customer complaint of reactive (positive) atellica im ahbs2 results that were non-reactive (negative) when tested on an alternate test method.Siemens' investigation included an assessment of the following: -reagent issues were ruled out based on review of quality control (qc) data that was provided by the customer which showed recovery within acceptable ranges.-siemens' internal release data was reviewed; reagent lot 175 medical decision pool (mdp) recovery was comparable to the previous lot and following lot of ahbs2.-a review of complaints did not identify a trend for this type of issue for this or any lot numbers for ahbs2 assay.-return of the patient samples was not possible as the sample volume was insufficient to allow for additional analysis, including heterophilic antibody interference testing or repeat testing.Per the atellica im anti-hepatitis b surface antigen 2 (ahbs2) ifu (10995277_en rev.07, 2024-02): "assay performance characteristics have not been established for the atellica im ahbs2 assay used in conjunction with other manufacturers' assays for specific hbv serological markers.Laboratories are responsible for establishing their own performance characteristics.Difference in competitor platform results can be attributed to but not limited to antigen/antibody targets, capture and detection antibodies, and signal detection methods, reagent and kit variability, sample handling and matrix effects, biological variability and regulatory and manufacturing standards." "results of this assay should always be interpreted in conjunction with the patient's medical history, clinical presentation, and other findings." based on the available information, the cause of the discordant result could not be determined, but a product problem was not identified.The customer resumed normal operations after retesting, and the issue has been resolved through routine troubleshooting.
 
Event or Problem Description
The customer obtained reactive (positive) atellica im ahbs2 results on atellica im analyzer s/n (b)(6).Results were reported to the physician and questioned.When the samples were retested on an alternate method, results were non-reactive (negative).There are no allegations of patient or user intervention or adverse health consequences due to the event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATELLICA IM ANTI-HEPATITIS B SURFACE ANTIGEN 2 (AHBS2)
Common Device Name
TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS INC
511 benedict ave
tarrytown NY 10591
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
333 coney st.
registration # 1219913
east walpole MA 02032
Manufacturer Contact
stacy loukos
333 coney st.
east walpole, MA 02032
MDR Report Key22642240
Report Number1219913-2025-00150
Device Sequence Number12952497
Product Code LOM
UDI-Device Identifier00630414597836
UDI-Public(01)00630414597836(10)76099175(17)261021
Combination Product (Y/N)N
Initial Reporter CountrySZ
PMA/510(K) Number
P100039
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 07/29/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberN/A
Device Catalogue Number10995453
Device Lot Number76099175
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/15/2025
Initial Report FDA Received Date07/29/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured10/21/2024
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-